Trials / Sponsors / BRIM Biotechnology Inc.
BRIM Biotechnology Inc.
Industry · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease Dry Eye Disease (DED), Keratoconjunctivitis Sicca | Phase 2 | 2025-12-01 |
| Recruiting | Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Ker Neurotrophic Keratitis | Phase 2 | 2024-07-31 |
| Completed | Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects. Dry Eye Disease | Phase 3 | 2023-02-27 |
| Completed | Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment Dry Eye Syndrome | Phase 2 / Phase 3 | 2020-01-15 |
| Completed | Safety and Efficacy of BRM421 for Dry Eye Syndrome Dry Eye Syndrome | Phase 2 | 2017-02-07 |
| Available | BRM421 Ophthalmic Solution in Patients With Limbal Stem Cell Deficiency Limbal Stem Cell Deficiency (LSCD) | — | — |